MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE

Pathology and Oncology Research

Volumn 20, Issue 1, 2014, Pages 93-98

  Chang, Liang ^a   Guo, Fengjie ^b   Wang, Yudong ^a   Lv, Yalei ^a   Huo, Bingjie ^a   Wang, Long ^a   Liu, Wei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance; Gastric cancer; MicroRNA 200c; RhoE

Indexed keywords

CISPLATIN; MICRORNA 200C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOE PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AKT GENE; ARTICLE; BAX GENE; BCL 2 GENE; CANCER CELL; CANCER CHEMOTHERAPY; CELL STRAIN SGC7901; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG RESISTANCE; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; PROTEIN EXPRESSION; PTEN GENE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RHOE GENE; ROCK1 GENE; STOMACH CANCER; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; RHO GTP-BINDING PROTEINS; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84896028412     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9664-7     Document Type: Article

References (28)

1. Lee JH, Kim KM, Cheong JH, Noh SH (2012) Current management and future strategies of gastric cancer. Yonsei Med J 53(2):248-257
2. Hudler P (2012) Genetic aspects of gastric cancer instability. Sci World J 2012:761909
3. Zhang H, Sun LL, Meng YL, Song GY, Hu JJ, Lu P, Ji B (2011) Survival trends in gastric cancer patients of Northeast China.World J Gastroenterol 17(27):3257-3262
4. Maconi G, Manes G, Porro GB (2008) Role of symptoms in diagnosis and outcome of gastric cancer. World J Gastroenterol 14(8):1149-1155 (Pubitemid 351356320)
5. Sun F, Lu X, Li H, Peng Z, Wu K, Wang G, Tong Q (2012) Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cells. Oncol Lett 4(1):156-162
6. Schoof CR, Botelho EL, Izzotti A, Vasques Ldos R (2012) MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2(4):414-433
7. Dontu G, de Rinaldis E (2010) MicroRNAs: shortcuts in dealing with molecular complexity? Breast Cancer Res 12(1):301
8. Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F, Esteller M (2012) Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 31(16):2062-2074
9. Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons DL, Baird BN, Alvarez C, Thilaganathan N, Liu DD, Saintigny P, Heymach JV, Creighton CJ, Kurie JM (2011) miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res 9(1):25-35
10. Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, Fujita H, Nakata K, Tanaka M (2010) MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 9:169
11. Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, Allgayer H (2010) Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res 8(9):1207-1216
12. Chen J, Tian W, Cai H, He H, Deng Y (2012) Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol 29(4):2527-2534
13. Madigan JP, Bodemann BO, Brady DC, Dewar BJ, Keller PJ, Leitges M, Philips MR, Ridley AJ, Der CJ, Cox AD (2009) Regulation of Rnd3 localization and function by protein kinase C alpha-mediated phosphorylation. Biochem J 424(1):153-161
14. Riento K, Villalonga P, Garg R, Ridley A (2005) Function and regulation of RhoE. Biochem Soc Trans 33(Pt 4):649-651 (Pubitemid 41160830)
15. Villalonga P, Guasch RM, Riento K, Ridley AJ (2004) RhoE inhibits cell cycle progression and Ras-induced transformation. Mol Cell Biol 24(18):7829-7840 (Pubitemid 39167435)
16. Li K, Lu Y, Liang J, Luo G, Ren G, Wang X, Fan D (2009) RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun 379(2):212-216
17. Issabekova A, Berillo O, Regnier M, Anatoly I (2012) Interactions of intergenic microRNAs with mRNAs of genes involved in carcinogenesis. Bioinformation 8(11):513-518
18. Hong L, Han Y, Lu Q, Zhang H, Zhao Q, Wu K, Fan D (2012) Drug resistance-related microRNAs in esophageal cancer. Expert Opin Biol Ther 12(11):1487-1494
19. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9(6):582-589 (Pubitemid 351772923)
20. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68(19):7846-7854
21. Jurmeister S, Baumann M, Balwierz A, Keklikoglou I, Ward A, Uhlmann S, Zhang JD, Wiemann S, Sahin Ö (2012) MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol 32(3):633-651
22. Lo WL, Yu CC, Chiou GY, Chen YW, Huang PI, Chien CS, Tseng LM, Chu PY, Lu KH, Chang KW, Kao SY, Chiou SH (2011) MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 223(4):482-495
23. Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK (2009) MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther 8(5):1055-1066
24. Leskelä S, Leandro-García LJ, Mendiola M, Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo A, de Santiago J, Robledo M, Hardisson D, Rodríguez-Antona C (2010) The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer 18(1):85-95
25. Collett GP, Goh XF, Linton EA, Redman CW, Sargent IL (2012) RhoE is regulated by cyclic AMP and promotes fusion of human BeWo choriocarcinoma cells. PLoS One 7(1):e30453
26. Poch E, Miñambres R, Mocholí E, Ivorra C, Pérez-Aragó A, Guerri C, Pérez-Roger I, Guasch RM (2007) RhoE interferes with Rb inactivation and regulates the proliferation and survival of the U87 human glioblastoma cell line. Exp Cell Res 313(4):719-731 (Pubitemid 46198817)
27. Cuiyan Z, Jie H, Fang Z, Kezhi Z, Junting W, Susheng S, Xiaoli F, Ning L, Xinhua M, Zhaoli C, Kang S, Bin Q, Baozhong L, Sheng C, Meihua X, Jie H (2007) Overexpression of RhoE in Non-small Cell Lung Cancer (NSCLC) is associated with smoking and correlates with DNA copy number changes. Cancer Biol Ther 6(3):335-342 (Pubitemid 47328299)
28. Klein RM, Higgins PJ (2011) A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition. Mol Cancer 10:114